Crinetics Pharmaceuticals (CRNX) Common Equity (2017 - 2026)
Crinetics Pharmaceuticals' Common Equity was $1.19 billion in Q2 2026, up 1.7% from $1.17 billion a year earlier but down 6.9% from the prior quarter.
Crinetics Pharmaceuticals (CRNX) Common Equity (2017 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Crinetics Pharmaceuticals came in at $992.08 million, down 25.1% from FY2024.
- Common Equity shows a five-year compound annual growth rate of 42.5% (FY2020 to FY2025).
- In earlier years, Common Equity was $1.32 billion in FY2024 (+145.7%), $539.11 million in FY2023 (+70.4%), $316.33 million in FY2022 (-4.7%) and $331.94 million in FY2021 (+96.5%).
- Quarterly Common Equity has moved between $193.59 million (Q3 2021) and $1.32 billion (Q4 2024) over five years.
- Compared with a year earlier, Common Equity was higher in seven of the last eight quarters, with growth averaging 36.2%.
- The best year-over-year quarter for Common Equity over five years was Q2 2024 (growth of 226.9%); the worst was Q2 2023 (a decline of 34.2%).
- Per Business Quant data, CRNX's Common Equity in the three quarters before Q2 2026 was $1.28 billion (Q1 2026), $992.08 million (Q4 2025) and $1.07 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Crinetics Pharmaceuticals | 8.99 Bn | 8.99 Bn | 24.96 Mn | 1.19 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.19 Bn |
| Mar 31, 2026 | 1.28 Bn |
| Dec 31, 2025 | 992.08 Mn |
| Sep 30, 2025 | 1.07 Bn |
| Jun 30, 2025 | 1.17 Bn |
| Mar 31, 2025 | 1.25 Bn |
| Dec 31, 2024 | 1.32 Bn |
| Sep 30, 2024 | 832.98 Mn |
| Jun 30, 2024 | 830.76 Mn |
| Mar 31, 2024 | 874.93 Mn |
| Dec 31, 2023 | 539.11 Mn |
| Sep 30, 2023 | 547.75 Mn |
| Jun 30, 2023 | 254.12 Mn |
| Mar 31, 2023 | 280.33 Mn |
| Dec 31, 2022 | 316.33 Mn |
| Sep 30, 2022 | 351.37 Mn |
| Jun 30, 2022 | 386.17 Mn |
| Mar 31, 2022 | 303.04 Mn |
| Dec 31, 2021 | 331.94 Mn |
| Sep 30, 2021 | 193.59 Mn |
Crinetics Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CRNX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CRNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CRNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();